Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2003
05/15/2003WO2002029059A9 Nogo receptor homologs
05/15/2003WO2002026781A9 Ige receptor antagonists
05/15/2003WO2002014348A3 Glycoproteins and methods of use thereof
05/15/2003US20030093821 For therapy of human subject diagnosed for predisposition for increased serum cholesterol or LDL cholesterol
05/15/2003US20030093820 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
05/15/2003US20030093819 Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof
05/15/2003US20030092897 Antigen composition against mycoplasma
05/15/2003US20030092894 Conjugated antigen for use as tool in the treatment of cancer
05/15/2003US20030092892 Crosslinking, agglutination, purification
05/15/2003US20030092891 Expressed ligand - vascular intercellular signalling molecule
05/15/2003US20030092883 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer and nervous system disorders
05/15/2003US20030092882 Host cells containing multiple integrating vectors
05/15/2003US20030092881 Polypeptide for use in diagnosis and treatment of gastrointestinal disorders
05/15/2003US20030092684 Antiinflammatory agents, rheumatic diseases, autoimmune disease; administering tetracyclins
05/15/2003US20030092661 88kDa tumorigenic growth factor and antagonists
05/15/2003US20030092645 Cloning, expression, viral and delivery vectors and hosts
05/15/2003US20030092624 Denaturant (boiling and/or detergent) stable; various uses including de-aggregating and/or preventing aggregation of an aggregating protein such as beta-amyloid or prions, restoring enzyme activity, and immunization using fusion protein
05/15/2003US20030092604 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/15/2003US20030092188 Placental protein 13
05/15/2003US20030092164 Polypeptide use in the treatment of cell proliferative disorders
05/15/2003US20030092154 Novel molecules
05/15/2003US20030092147 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092133 Interleukins-21 and 22
05/15/2003US20030092125 Biasing the immune response of mammal; obtain phage display antibody library, recover peptide from library which binds specific antibody, immunize mammal
05/15/2003US20030092122 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092120 Novel human K+ ion channel and therapeutic applications thereof
05/15/2003US20030092115 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092113 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092111 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092110 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092108 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092107 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092106 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092105 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092104 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092103 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092101 Human tumor necrosis factor receptors TR13 and TR14
05/15/2003US20030092094 Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies
05/15/2003US20030092091 Sialoadhesin factor-2 antibodies
05/15/2003US20030092088 Kit for use in the classification of mammalian blood
05/15/2003US20030092086 Method for detecting streptococcus sobrinus and antibody therefor
05/15/2003US20030092085 Antibody against glyceraldehyde-3-phosphate dehydrogenase and use thereof
05/15/2003US20030092082 Anti-human luteinizing hormone-related antibodies and uses thereof
05/15/2003US20030092080 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
05/15/2003US20030092078 Propagating and recovering preferential cells from culture; obtain cell sample, expose to antibody, separate cells bound to antibody, recover and propagate bound cells
05/15/2003US20030092068 Agents for adsorption and bridging for adenovirus
05/15/2003US20030092065 Peptide for use in the treatment and prevention of allergies
05/15/2003US20030092063 Nucleotide sequences coding polypeptide for use in the treatment of cancer and diabetes
05/15/2003US20030092061 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferation and tumor disorders
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030092057 Detection of ligands for preferential polypeptides; obtain sample, incubate with ligand sample, detect bound ligand
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030092044 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders
05/15/2003US20030092043 Melanoma differentiation associated gene - 5 and promoter and uses thereof
05/15/2003US20030092025 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment, prevention of tumor disorders
05/15/2003US20030092024 Essential bacterial genes and their use
05/15/2003US20030092014 Nucleotide sequences coding polypeptide for use in the generation of stress, disease and drought resistant plants
05/15/2003US20030092011 Human cDNAs and proteins and uses thereof
05/15/2003US20030092002 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030091996 Apoptin-associating protein
05/15/2003US20030091995 Generation of human antibody display library; obtain trangenic animal, transform with nucleotide sequence which code antibodies, form library of display packages displaying antibody chains
05/15/2003US20030091586 Fish immunoglobulin
05/15/2003US20030091584 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
05/15/2003US20030091581 Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes
05/15/2003US20030091580 Compositions and methods for the therapy and diagnosis of ovarian cancer
05/15/2003US20030091574 Combination treatment of pancreatic cancer
05/15/2003US20030091569 Methods for the treatment of carcinoma
05/15/2003US20030091568 Inhibitors for the formation of soluble human CD23
05/15/2003US20030091567 Antiinflammatory agents; anticancer agents
05/15/2003US20030091566 Antitumor agents
05/15/2003US20030091562 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
05/15/2003US20030091561 Anticancer agents
05/15/2003US20030091560 Composition for Pharmaceutical and Cosmetic Products
05/15/2003US20030091551 Tyrosone kinase as insulin receptor; antidiabetic agents
05/15/2003US20030091548 Gene therapy for the prevention of autoimmune disease
05/15/2003US20030091506 Methods of using 22417, a novel human aminoprotease family member
05/15/2003CA2504349A1 Monoclonal antibodies specific for beta-amyloid
05/15/2003CA2467853A1 Antibody stimulating il-1ra production
05/15/2003CA2466492A1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003CA2466138A1 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003CA2466128A1 Antibodies to cd40
05/15/2003CA2466049A1 Human monoclonal antibodies to dendritic cells
05/15/2003CA2465981A1 Antigen arrays comprising rankl for treatment of bone disease
05/15/2003CA2465953A1 Novel isoforms of vascular endothelial cell growth inhibitor
05/15/2003CA2465949A1 Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2464765A1 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003CA2463855A1 Weed controller metabolism proteins, genes thereof and use of the same
05/15/2003CA2462653A1 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
05/15/2003CA2462462A1 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/14/2003EP1310798A2 Cell tests and diagnostic index for Alzheimer's disease
05/14/2003EP1310796A2 Reagents for the simultaneous detection of HCV core antigens and antibodies
05/14/2003EP1310558A2 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
05/14/2003EP1310557A1 Design of bioactive peptides based on immunoglobulin structure
05/14/2003EP1310552A2 Posh nucleic acids, polypeptides and related methods
05/14/2003EP1310512A2 Hcv core protein sequences
05/14/2003EP1309718A2 Neutrokine-alpha and neutrokine-alpha splice variant
05/14/2003EP1309705A2 Multivalent target binding protein
05/14/2003EP1309703A2 Kallikrein gene
05/14/2003EP1309700A2 Human phosphodiesterases
1 ... 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 ... 1494